The Global Meningitis Imaging Market size is expected to reach $223.7 thousands by 2027, rising at a market growth of 4.3% CAGR during the forecast period.
Meningitis is a condition in which the brain and spinal cord become inflamed. It induces brain edoema, which resulted in symptoms including fever, headache, and stiff neck. Some kinds of meningitis are bacterial meningitis, viral meningitis, fungal meningitis, and others.
One of the most common causes of bacterial meningitis is ear and sinus infection. Bacteria like streptococcus pneumonia, neisseria meningitides, and haemophilus influenza are among them. The symptoms of viral meningitis are usually minor. Viruses such as HIV, mumps, herpes simplex virus, and west nile virus are included in this. Person-to-person transmission is one of the way causing fungus meningitis. If it is not treated in a timely manner, it can be fatal.
Acute bacterial meningitis is a common neurological emergency that is a primary cause of mortality and disability around the world. Neuroimaging in the form of CT is reserved for people with specific adverse clinical characteristics or when an underlying cause such as mastoiditis is suspected, and is based on clinical and microbiological findings. MRI is particularly helpful in diagnosing and monitoring meningitis complications.
Factors like increased prevalence of meningitis disease; rise in various types of meningitis such as bacterial meningitis, viral meningitis, and fungal meningitis; surge in cases of tuberculosis that causes bacterial meningitis; surge in usage of computed tomography scans to determine the infection are estimated to fuel the growth of the meningitis imaging market. In addition, there is a rise in demand for magnetic resonance imaging, positron emission tomography, and computed tomography scans to detect infection.
The COVID-19 outbreak is expected to have a positive impact on the worldwide meningitis imaging market. In the initial stage of the pandemic, a few cases of meningitis and covid-19 infection were reported simultaneously. In that instance, computed tomography and magnetic resonance imaging are the most effective instruments for identifying the infection and monitoring the treatment's success. There are many patients who went for meningitis imaging to determine the level of effects caused by the virus.
The therapeutic utility of CT was increased by implementing suitable preventative safety measures, optimizing chest CT protocols, and building a uniform reporting system based on pulmonary results in this condition. As a result of the increase of Covid-19 cases, the use of computed tomography scans is expected to drive the meningitis imaging market over the forecast period.
There is a rise in the cases of various infectious diseases and HIV, which creates more demand for meningitis imaging. As per the World Health Organization (WHO), approximately 38 million individuals are infected with HIV in 2020, which is increasing the cases of meningitis among people. HIV targets the immune system by killing CD4+ T cells, a kind of white blood cell that is essential for infection resistance. People infected with HIV are more susceptible to various infections, illnesses, and meningitis.
The prevalence of various diseases across the globe is motivating governments to invest a significant amount in R&D activities. Several healthcare vendors are increasing their investment in R&D to develop more advanced meningitis imaging devices and tools. In addition, governments are trying to make the healthcare facilities more accessible and inexpensive so that any person can be tested and receive proper treatment for the tested disease.
Since technologies and procedures used for meningitis imaging are highly technical, personnel who are using these technologies and devices need to be well-aware of their usage. Having sound knowledge of the machine and its operations is important to make full use of these devices. However, a lack of this knowledge can lead to severe problems. People operating CT and MRI machines need to get proper formal training to operate the machines in order to produce accurate results.
On the basis of product type, the meningitis imaging market is fragmented into Magnetic Resonance Imaging (MRI), Computer Tomography (CT) and Positron Emission Tomography. Magnetic Resonance Imaging (MRI) segment is anticipated to garner a significant revenue share in the market during the forecast period. This growth is attributed to the increase in the number of diagnostic centres and increasing investment by the key medical companies in the development of advanced MRI diagnostic machines.
Based on disease type, the meningitis imaging market is divided into Bacterial Meningitis, Viral Meningitis, Fungal Meningitis and others. The viral meningitis segment dominated the market with the maximum revenue share in 2020. It is owing to the rising cases of meningitis caused by virus along with the growing prevalence of HIV and other related diseases. Non-polio enteroviruses are among the key reasons behind viral meningitis in the US according to the CDC.
By end user, the meningitis imaging market is bifurcated into Hospitals & Clinics and Diagnostic Centers. In 2020, the Hospitals & Clinics segment acquired the maximum revenue share of the meningitis Imaging market Hospitals have a huge infrastructure to keep almost all the immediate required testing machines. The availability of advanced equipment and tools in hospitals would motivate patients to go to hospitals for better diagnosis and other healthcare services.
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 160.6 Thousands |
| Market size forecast in 2027 | USD 223.7 Thousands |
| Base Year | 2020 |
| Historical Period | 2017 to 2019 |
| Forecast Period | 2021 to 2027 |
| Revenue Growth Rate | CAGR of 4.3% from 2021 to 2027 |
| Number of Pages | 213 |
| Number of Tables | 353 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling |
| Segments covered | Product Type, Disease Type, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the meningitis imaging market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America dominated the meningitis imaging market in 2020 and is expected to continue to do so during the forecast period. This growth is attributed to the rising prevalence of inflammatory diseases, the presence of key players, the development of the healthcare sector, the presence of new innovative imaging systems, and advancements in computed tomography technology.
Free Valuable Insights: Global Meningitis Imaging Market size to reach USD 223.7 Thousands by 2027
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; General Electric (GE Healthcare) is the major forerunners in the Meningitis Imaging Market. Companies such as Canon, Inc. (Canon Medical Systems Corporation), Fujifilm Holdings Corporation, Koninklijke Philips N.V. are some of the key innovators in the Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shimadzu Corporation, Accuray, Incorporated, United Imaging Healthcare Co., Ltd., Positron Corporation, Neusoft Medical Systems Co., Ltd. (Neusoft Corporation), Siemens AG (Siemens Healthineers), Fujifilm Holdings Corporation, General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., and Canon, Inc. (Canon Medical Systems Corporation).
By Product Type
By Disease Type
By End User
By Geography
The meningitis imaging market size is projected to reach USD 223.7 thousands by 2027.
Rising cases of HIV and other infectious diseases are driving the market in coming years, however, lack of skilled professionals limited the growth of the market.
Shimadzu Corporation, Accuray, Incorporated, United Imaging Healthcare Co., Ltd., Positron Corporation, Neusoft Medical Systems Co., Ltd. (Neusoft Corporation), Siemens AG (Siemens Healthineers), Fujifilm Holdings Corporation, General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., and Canon, Inc. (Canon Medical Systems Corporation).
The increase of Covid-19 cases, the use of computed tomography scans is expected to drive the meningitis imaging market over the forecast period.
The Computer Tomography (CT) market dominated the Global Meningitis Imaging Market by Product Type 2020, and would continue to be a dominant market till 2027.
The North America market dominated the Global Meningitis Imaging Market by Region 2020, and would continue to be a dominant market till 2027.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 